McCulloch Kevin 4
4 · Xeris Biopharma Holdings, Inc. · Filed Aug 2, 2024
Insider Transaction Report
Form 4
McCulloch Kevin
See Remarks
Transactions
- Award
Stock Appreciation Right
2024-08-01+200,000→ 200,000 totalExercise: $2.43Exp: 2026-09-01→ Common Stock (200,000 underlying) - Award
Common Stock
2024-08-01+150,000→ 1,601,953 total
Footnotes (2)
- [F1]The award will vest in full on the two-year anniversary of the grant date.
- [F2]Upon exercise, the Stock Appreciation Right will be settled in cash.